475
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Are there alternative ways to quantify the real benefit of novel agents in oncology? – the ‘death pace’

Pages 187-188 | Received 27 Oct 2014, Accepted 18 Dec 2014, Published online: 10 Mar 2015

References

  • Goey AK, Figg WD. Potential novel role of bevacizumab in glioblastoma and cervical cancer. Cancer Biol Ther 2014 Oct; 15(10):1296-8; Epub 2014 Jul 21; PMID:25046485; http://dx.doi.org/10.4161/cbt.29926
  • Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014; 370:734-43; PMID:24552320; http://dx.doi.org/10.1056/NEJMoa1309748

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.